The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia.
Ingrid A CoxBarbara de GraaffHasnat AhmedJulie CampbellPetr OtahalTamera J CorteIan GlaspoleYuben MoodleyNicole GohSacha MacanshE Haydn WaltersAndrew J PalmerPublished in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2021)
Our study has shown that EQ-5D-5L has exhibited discriminatory sensitivity for the study population. We have demonstrated that disease severity and having more than two comorbidities was associated with lower HSUVs in Australians with IPF. Our findings support early diagnosis and appropriate evidence-based treatment to slow or prevent IPF progression; and identification and treatment of associated comorbidities to potentially improve health-related quality of life in people with IPF.